A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer-Reference-Cited by-同舟云学术

A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer

Published:2023-03 Issue: Volume:181 Page:70-78
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Fankhauser Christian D.^ORCID,Parry Matthew G.^ORCID,Ali Adnan,Cowling Thomas E.,Nossiter Julie,Sujenthiran Arun,Berry Brendan,Morris Melanie,Aggarwal Ajay,Payne Heather,van der Meulen Jan^ORCID,Clarke Noel W.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Clinical and genomic characterization of low–prostate-specific antigen, high-grade prostate cancer;Mahal;Eur Urol,2018

2. Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer;Mahal;Cancer,2016

3. Inferior cancer survival for men with localized high-grade prostate cancer but low prostate-specific antigen;Fankhauser;Eur Urol,2020

4. Association of very low PSA with increased metastases and death in patients with biopsy Gleason score 8-10 prostate cancer;Pompe;Euro Urol Open Sci,2020

5. Outcomes in patients with Gleason score 8–10 prostate cancer: relation to preoperative PSA level;McGuire;BJU Int,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review;BJUI Compass;2024-01-31

2. Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels;JAMA Network Open;2023-11-01

3. Low PSA radiographic disease progression on C11‐choline PET;BJUI Compass;2023-10-25

4. Re: A low prostate-specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer;European Journal of Cancer;2023-07